News
- Author:
- Mary Jo M. Dales
Publish date: August 31, 2019
All cases appear linked to e-cigarette product use, but the cause of the respiratory illnesses is still unconfirmed.
News
- Author:
- Mary Jo M. Dales
Publish date: August 15, 2019
Rozlytrek becomes the third tissue-agnostic therapy to gain FDA approval.
News
- Author:
- Mary Jo M. Dales
Publish date: August 2, 2019
Turalio is the first therapy approved for the rare joint tumor and is available only through the Turalio Risk Evaluation and Mitigation (REMS) Prog...
News
- Author:
- Mary Jo M. Dales
Publish date: July 29, 2019
The streamlined approach to diagnosis may speed treatment of Lyme disease.
News
- Author:
- Mary Jo M. Dales
Publish date: July 3, 2019
The oral therapy was approved for patients who have received at least four prior therapies and whose disease is resistant to several other forms of...
News
- Author:
- Mary Jo M. Dales
Publish date: June 7, 2019
Patients can use the device for up to 3 consecutive weeks to reduce functional abdominal pain associated with IBS.
News
- Author:
- Mary Jo M. Dales
Publish date: May 13, 2019
Biologics deemed “interchangeable” will be able to be substituted without the involvement of the prescriber.
News
- Author:
- Mary Jo M. Dales
Publish date: May 8, 2019
The approval is the first for a LEMS treatment specifically for pediatric patients.
News
- Author:
- Mary Jo M. Dales
Publish date: November 30, 2018
The Alethia CMV Assay Test System detects CMV DNA obtained via a saliva swab.
News
- Author:
- Mary Jo M. Dales
Publish date: October 8, 2018
SAN ANTONIO - Obese patients with asthma or COPD typically have metabolic and inflammatory profiles that differ from those of nonobese patients wit...
News
- Author:
- Mary Jo M. Dales
Publish date: October 5, 2018
Aberrations in oncogenic pathways and immune modulation influence treatment response in patients with metastatic leiomyosarcoma or liposarcoma.
News
- Author:
- Mary Jo M. Dales
Publish date: September 29, 2018
The assay is the first next generation sequencing–based test to be granted marketing approval for detecting minimal residual disease in patients wi...
News
- Author:
- Mary Jo M. Dales
Publish date: September 26, 2018
News
- Author:
- Mary Jo M. Dales
Publish date: September 7, 2018
A new dosage strength of buprenorphine and naloxone sublingual film has been approved by the FDA.
News
- Author:
- Mary Jo M. Dales
Publish date: September 1, 2018
The statistical significance of the improvements varied depending on how progression-free survival was measured.
